The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
The 40-second film brings children to the forefront of the narrative
Supported by Plan International, the partnership will help treat over 1,000 children annually
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
Subscribe To Our Newsletter & Stay Updated
